Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI — Stella

Recruiting

Back to Heart Attack trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

Minneapolis Heart Institute Foundation, Minneapolis, Minnesota

Key details

Phase

Safety & dosing

Sponsor

Minneapolis Heart Institute Foundation

Enrollment target

~81 participants

Started

August 2022

Primary completion

December 2028

Age range

18 Years – 75 Years

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov